kin-2 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to KIN Antibodies

The term "kin-2 Antibody" primarily refers to antibodies targeting the DNA/RNA-binding protein KIN17 (UniProt ID: O60870), a conserved nuclear protein involved in DNA replication, damage response, and mRNA processing . While Saccharomyces cerevisiae Kin2 is a distinct Par-1/MARK-family kinase regulating secretion and septin organization , this article focuses on mammalian KIN17-targeting antibodies due to their well-characterized applications in molecular biology.

Target Protein: DNA/RNA-binding Protein KIN17

KIN17 is a 45.4 kDa protein with dual DNA/RNA-binding capabilities . Key features include:

PropertyDetails
Molecular FunctionBinds curved DNA, RNA; regulates DNA replication/repair complexes .
Subcellular LocalizationNucleus .
Tissue SpecificityUbiquitous; highest in skeletal muscle, heart, and testis .
OrthologsConserved in mammals (human, mouse, rat), zebrafish, and Xenopus .

Antibody Development and Characteristics

Commercial KIN antibodies (e.g., Novatein Biosciences ASA-B1122, Boster Bio PA2238) are typically rabbit polyclonal IgG generated against a synthetic peptide corresponding to residues 48–64 of human KIN17 .

ParameterSpecification
Host SpeciesRabbit
ReactivityHuman, Mouse, Rat
ImmunogenSynthetic peptide (ESHQRQLLLASENPQQF) at N-terminus .
ApplicationsWestern blot (0.1–0.5 μg/ml) .
StorageLyophilized; stable at -20°C for 12 months .

These antibodies detect a single band at ~45 kDa in Western blots, confirming specificity for KIN17 .

DNA Damage and Replication Studies

KIN17 antibodies have been instrumental in identifying the protein’s role in:

  • Bridging DNA replication and repair via high-molecular-weight complexes .

  • Localizing to replication factories during S phase .

  • Binding curved DNA structures in vitro and in vivo, suggesting involvement in chromatin remodeling .

Cancer Research

KIN17 is differentially expressed in tumorigenic vs. non-tumorigenic cell lines . Antibody-based studies revealed:

  • Elevated levels in proliferating epithelial keratinocytes .

  • Association with metastatic potential in murine models .

Cross-reactivity and Related Proteins

While KIN antibodies target mammalian KIN17, S. cerevisiae Kin2 shares no sequence homology but exemplifies nomenclature overlap. Yeast Kin2 (UniProt: P36005) is a 1147-aa kinase regulating:

  • Secretory pathway: Suppresses sec1-1, sec4-P48, and other secretion mutants .

  • Septin organization: Interacts with Cdc11 and Pea2; overexpression disrupts chitin deposition .

  • ER stress response: Kin2 kinase domain alone restores UPR in hac1Δ mutants .

FeatureKIN17 (Mammals)Kin2 (Yeast)
Molecular Weight45.4 kDa127.5 kDa
LocalizationNucleusPlasma membrane, polarized growth sites .
Key InteractionsDNA/RNA, replication complexesCdc11 (septin), Bmh1 (14-3-3) .

Future Directions in KIN Antibody Research

Current gaps include:

  • Structural characterization of KIN17-antibody complexes for epitope mapping.

  • Role of KIN17 phosphorylation in cancer progression .

  • Potential cross-species applications in yeast or other models to study functional parallels.

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
kin-2 antibody; kin-a antibody; R07E4.6 antibody; cAMP-dependent protein kinase regulatory subunit antibody
Target Names
kin-2
Uniprot No.

Target Background

Function
This antibody targets a protein that likely regulates rhythmic enteric muscle contractions. It achieves this by modulating calcium influx in GABAergic DVB neurons via the G-protein coupled receptor aex-2.
Database Links

KEGG: cel:CELE_R07E4.6

STRING: 6239.R07E4.6c

UniGene: Cel.5527

Protein Families
CAMP-dependent kinase regulatory chain family
Subcellular Location
Cytoplasm, cytosol.

Q&A

What is Kin-2 and why is it significant in cellular research?

Kin-2 (also known as Kin2) is a serine/threonine kinase that plays multiple critical roles in cellular function. Originally characterized for its involvement in cell polarity and exocytosis, recent research has revealed Kin-2's novel function in regulating the unfolded protein response (UPR) . The protein contains an N-terminal kinase domain and a C-terminal regulatory domain followed by a kinase-associated domain 1 (KA1) . Antibodies against Kin-2 are crucial research tools for investigating these pathways, particularly in studying stress response mechanisms.

How do Kin-2 antibodies help elucidate protein localization patterns?

Kin-2 antibodies are instrumental in determining the subcellular localization of Kin-2 kinase. Research using GFP-tagged Kin2 has shown that the protein is predominantly cytoplasmic, appearing as discrete dots or foci inside the cell . This contradicts earlier assumptions about its exclusive plasma membrane localization. Antibodies against different domains of Kin-2 allow researchers to track its distribution across cellular compartments, providing insights into how this kinase functions as an endomembrane protein that influences the endoplasmic reticulum (ER) stress response directly through substrate phosphorylation .

What structural domains of Kin-2 should antibodies target for optimal detection?

For optimal detection of Kin-2, researchers should consider targeting antibodies against:

  • The N-terminal kinase domain (residues R94 to A526): This domain is functionally sufficient to activate the UPR and constitutes the catalytically active region .

  • The predicted transmembrane region (residues F30 to Q67): This region helps anchor the protein to membranes .

  • The C-terminal KA1 domain (residues K1116 to L1147): This domain may play a role in membrane binding and regulation .

Antibodies targeting these specific domains allow for more nuanced studies of Kin-2 structure-function relationships and potential membrane interactions.

How can phospho-specific Kin-2 antibodies distinguish between active and inactive forms of the kinase?

Phospho-specific antibodies against Kin-2 activation sites are essential for distinguishing between its active and inactive forms. The kinase activity of Kin-2 is crucial for its function, as demonstrated by studies showing that kinase-dead derivatives (such as the D248A mutation) fail to restore UPR function in yeast models . A methodological approach involves using phospho-specific antibodies in western blotting experiments alongside total Kin-2 antibodies to calculate the ratio of phosphorylated to total Kin-2, providing a quantitative measure of kinase activation under different stress conditions or genetic backgrounds.

What cross-reactivity considerations are important when using Kin-2 antibodies in multi-protein family studies?

When studying Kin-2 in the context of related kinases, researchers must consider potential cross-reactivity with paralogues such as Kin1. These kinases share significant sequence homology and functional redundancy . To ensure specificity:

  • Validate antibodies against recombinant Kin1 and Kin2 proteins

  • Use kin1Δ and kin2Δ deletion strains as negative controls in yeast studies

  • Employ epitope-mapping to identify unique regions for generating more specific antibodies

  • Confirm specificity through immunoprecipitation followed by mass spectrometry

This is particularly important when investigating whether Kin1 and Kin2 have distinct or overlapping functions in cellular stress responses.

How can Kin-2 antibodies help characterize the UPR signaling network beyond the canonical Ire1 pathway?

Kin-2 antibodies serve as crucial tools for dissecting the relationship between Kin-2 kinase and the canonical Ire1-mediated UPR pathway. Research indicates that Kin kinases likely constitute an independent signaling cascade that augments cellular adaptation to ER stress, as evidenced by differential sensitivities to tunicamycin observed in ire1Δ versus kin1Δ kin2Δ strains . Methodologically, researchers can use co-immunoprecipitation with Kin-2 antibodies followed by mass spectrometry to identify novel interacting partners in the UPR network. This approach can reveal how Kin-2 signaling interfaces with Ire1-dependent pathways and potentially identify new therapeutic targets for ER stress-related diseases.

What are the optimal fixation and permeabilization protocols for Kin-2 immunolocalization studies?

For successful immunolocalization of Kin-2, the following methodological approach is recommended:

Protocol StepMembrane-Associated Kin-2Cytoplasmic Kin-2
Fixation4% paraformaldehyde, 15 min at room temperature4% paraformaldehyde with 0.1% glutaraldehyde, 20 min at room temperature
Permeabilization0.1% Triton X-100, 10 min0.5% Saponin, 15 min
Blocking3% BSA in PBS, 1 hour5% BSA in PBS with 0.1% Saponin, 1 hour
Primary antibody incubationAnti-Kin-2 (1:200), overnight at 4°CAnti-Kin-2 (1:100), overnight at 4°C
VisualizationConfocal microscopy with membrane markersSuper-resolution microscopy for foci localization

This dual approach accommodates the complex localization pattern of Kin-2, which has been shown to form discrete cytoplasmic foci while also associating with membrane fractions . The protocol can be further optimized by co-staining with markers for specific endomembrane compartments to precisely determine the subcellular localization of Kin-2.

How should researchers design antibody-based experiments to investigate Kin-2's role in HAC1 mRNA regulation?

To investigate Kin-2's role in HAC1 mRNA regulation, researchers should implement a multi-methodological approach:

  • RNA immunoprecipitation (RIP) using Kin-2 antibodies to assess direct binding to HAC1 mRNA

  • Immunofluorescence combined with RNA FISH to visualize co-localization of Kin-2 protein with HAC1 mRNA

  • Chromatin immunoprecipitation (ChIP) to determine if Kin-2 associates with HAC1 promoter regions

  • Proximity ligation assays (PLA) between Kin-2 and RNA processing machinery

This comprehensive approach allows researchers to determine whether Kin-2's effects on HAC1 mRNA targeting, splicing, and translation involve direct interactions or indirect regulatory mechanisms. Quantitative analysis of these interactions in wild-type versus mutant strains (particularly HAC1-GG1143-1144CC variants) can reveal how Kin-2 overcomes defective UPR associated with HAC1 mutations.

What control experiments are essential when using Kin-2 antibodies in stress response studies?

When utilizing Kin-2 antibodies in stress response research, the following controls are essential:

  • Genetic controls:

    • kin1Δ kin2Δ double knockout strains as negative controls

    • Complementation with wild-type KIN2 versus kinase-dead variants (D248A mutation)

  • Stress condition controls:

    • Tunicamycin treatment time course (acute vs. prolonged exposure)

    • Comparison with other ER stressors (DTT, thapsigargin)

  • Antibody specificity controls:

    • Pre-absorption with recombinant Kin-2 protein

    • Secondary antibody-only controls

    • Cross-reactivity assessment with Kin1

  • Functional validation:

    • Parallel assessment of UPR activation via HAC1 splicing

    • Monitoring of downstream UPR target gene expression

These controls ensure that observed phenotypes genuinely reflect Kin-2's function in stress responses and are not artifacts of experimental conditions or antibody cross-reactivity.

How can researchers overcome challenges in detecting membrane-associated Kin-2 populations?

Detecting membrane-associated Kin-2 populations presents specific challenges due to its complex localization pattern. Researchers have noted that Kin-2 precipitates with membrane fractions despite lacking extensive hydrophobic sequences typically associated with transmembrane domains . To overcome these challenges:

  • Use membrane fractionation techniques that separate different cellular compartments

  • Employ membrane-specific extraction buffers containing appropriate detergents (CHAPS or digitonin rather than Triton X-100)

  • Consider cross-linking approaches before immunoprecipitation

  • Target antibodies specifically against the predicted membrane-binding region (residues F30 to Q67)

  • Use super-resolution microscopy techniques (STORM, PALM) for improved visualization of membrane-associated populations

These approaches help distinguish between cytoplasmic foci and genuine membrane associations, providing more accurate insights into Kin-2's subcellular distribution and functional compartmentalization.

What factors should be considered when interpreting contradictory results between Kin-2 antibody detection and GFP-fusion localization?

When faced with discrepancies between antibody-based detection and GFP-fusion protein localization of Kin-2, researchers should consider:

Potential IssueInvestigation MethodResolution Strategy
Antibody specificityWestern blot with recombinant proteinGenerate new antibodies against different epitopes
Epitope masking in certain conformationsUse multiple antibodies targeting different regionsPerform mild denaturation to expose hidden epitopes
GFP fusion interference with localizationCompare N-terminal vs. C-terminal tagsUse smaller tags (FLAG, HA) or split-GFP approaches
Fixation artifactsTest multiple fixation protocolsUse live-cell imaging with appropriate controls
Dynamic localization changesTime-course experimentsHigh-temporal resolution live imaging

Research has shown that GFP-Kin2 fusion proteins display a punctate pattern inside the cytoplasm, contrasting with earlier assumptions about exclusive membrane localization . These differing results highlight the importance of using complementary approaches when studying proteins with complex localization patterns.

How can epitope mapping improve the specificity of Kin-2 antibodies for distinguishing between homologous kinases?

To improve specificity of antibodies for Kin-2 versus its paralogue Kin1, systematic epitope mapping provides several advantages:

  • Identification of unique regions: Computational analysis can identify sequences unique to Kin-2 not present in Kin1

  • Domain-specific antibodies: Generate antibodies against:

    • The N-terminal kinase domain (more conserved but functionally critical)

    • The C-terminal regulatory region (typically more divergent between paralogues)

    • The kinase-associated domain 1 (KA1) (potentially unique regulatory interactions)

  • Validation approach:

    • Test antibodies against recombinant Kin1 and Kin2 proteins

    • Verify in kin1Δ and kin2Δ deletion strains

    • Confirm specificity through mass spectrometry of immunoprecipitated proteins

This systematic approach is particularly important given the functional redundancy observed between Kin1 and Kin2 in certain cellular contexts while maintaining distinct roles in others .

How might autoantibodies against Kin-2-like proteins contribute to post-infectious conditions?

Recent research into post-infectious conditions has revealed the potential role of autoantibodies in persistent symptoms following infections . While not directly studied in the context of Kin-2, the presence of autoantibodies against cellular kinases and regulatory proteins could disrupt normal cellular stress responses. Methodologically, researchers investigating this connection should:

  • Screen patient sera for autoantibodies against Kin-2 and related kinases

  • Assess functional consequences of these autoantibodies on UPR and cellular stress responses

  • Determine cell type-specific effects of autoantibody binding to Kin-2

  • Evaluate temporal relationships between autoantibody production and symptom persistence

This research direction could reveal whether disruption of Kin-2-mediated stress response pathways contributes to persistent cellular dysfunction in post-infectious conditions.

What insights can phosphoproteomics combined with Kin-2 antibody-based enrichment provide about stress-induced kinase cascades?

Combining phosphoproteomics with Kin-2 antibody-based enrichment could revolutionize our understanding of stress-induced kinase cascades:

  • Methodological approach:

    • Immunoprecipitate Kin-2 complexes from cells under normal and stress conditions

    • Identify co-precipitating proteins and their phosphorylation status by mass spectrometry

    • Validate findings with phospho-specific antibodies

    • Confirm direct phosphorylation using in vitro kinase assays

  • Expected insights:

    • Identification of direct Kin-2 substrates during stress responses

    • Mapping of signaling cascades connecting Kin-2 to the canonical Ire1 pathway

    • Discovery of novel regulatory mechanisms for HAC1 mRNA processing

    • Understanding temporal dynamics of Kin-2 activation during stress

This approach could expand our understanding of how Kin-2 constitutes an independent signaling cascade that augments cellular adaptation to ER stress , potentially identifying new therapeutic targets.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.